01 1Polypeptide Laboratories San Diego, LLC
01 1ANGIOTENSIN II ACETATE
01 1Switzerland
NDC Package Code : 58862-0176
Start Marketing Date : 2017-12-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
89
PharmaCompass offers a list of Angiotensin II API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Angiotensin II manufacturer or Angiotensin II supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Angiotensin II manufacturer or Angiotensin II supplier.
A Angiotensin II Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Angiotensin II Acetate, including repackagers and relabelers. The FDA regulates Angiotensin II Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Angiotensin II Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Angiotensin II Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Angiotensin II Acetate supplier is an individual or a company that provides Angiotensin II Acetate active pharmaceutical ingredient (API) or Angiotensin II Acetate finished formulations upon request. The Angiotensin II Acetate suppliers may include Angiotensin II Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Angiotensin II Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Angiotensin II Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Angiotensin II Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Angiotensin II Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Angiotensin II Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Angiotensin II Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Angiotensin II Acetate suppliers with NDC on PharmaCompass.
We have 1 companies offering Angiotensin II Acetate
Get in contact with the supplier of your choice:
